ERN eUROGEN, the European Reference Network for Rare Urogenital Diseases and Complex Conditions, proudly supports the European Association of Urology (EAU) in its “An Urge to Act” campaign, a crucial step in addressing incontinence as a significant public health issue. Affecting millions across Europe, incontinence remains a stigmatized condition that often goes untreated due to underreporting, lack of awareness, and limited access to care.
The “An Urge to Act” campaign seeks to change this by advocating for better policies, increased research, and wider access to incontinence care. Incontinence can profoundly impact individuals’ quality of life, from physical discomfort to emotional distress and social isolation. For patients with rare urogenital diseases and complex conditions—a key focus for ERN eUROGEN—urinary incontinence is often a secondary issue, complicating already challenging medical situations.
This campaign aligns closely with ERN eUROGEN’s mission to advance care for patients facing complex urogenital conditions by advocating for early diagnosis, improved care standards, and access to specialised treatments. “An Urge to Act” calls on healthcare providers, policymakers, and patient advocacy groups to collaborate in developing robust strategies to address incontinence’s social and economic burden across Europe.
Through our network of specialised centres, ERN eUROGEN seeks to contribute to this effort by sharing expertise, raising awareness, and supporting innovations in care and management. We believe that concerted efforts, such as this campaign, will improve continence care and the overall well-being of patients with rare urogenital diseases.
Together, we can foster a European healthcare system that recognizes the importance of continence health and ensures that no one is left behind.
For more details, visit An Urge to Act.
